Myosin VI plays important roles in endocytic and exocytic membrane trafficking pathways in cells. Since recent work has highlighted the importance of targeted membrane transport during cytokinesis, we investigated whether myosin VI plays a role in this process during cell division. In dividing cells myosin VI undergoes dramatic changes in localisation: in prophase myosin VI is recruited to the spindle poles and in cytokinesis myosin VI is targeted to the walls of the ingressing cleavage furrow with a dramatic concentration in the midbody region. Furthermore, myosin VI is present on vesicles moving into and out of the cytoplasmic bridge connecting the two daughter cells. 
Abstract
Myosin VI plays important roles in endocytic and exocytic membrane trafficking pathways in cells. Since recent work has highlighted the importance of targeted membrane transport during cytokinesis, we investigated whether myosin VI plays a role in this process during cell division. In dividing cells myosin VI undergoes dramatic changes in localisation: in prophase myosin VI is recruited to the spindle poles and in cytokinesis myosin VI is targeted to the walls of the ingressing cleavage furrow with a dramatic concentration in the midbody region. Furthermore, myosin VI is present on vesicles moving into and out of the cytoplasmic bridge connecting the two daughter cells.
Inhibition of myosin VI activity by siRNA mediated knock down or by overexpression of dominant negative myosin VI tail leads to a delay in metaphase progression and a defect in cytokinesis. GIPC, a myosin VI binding partner, is associated with myosin VI's function(s) in dividing cells. Loss of GIPC in siRNA knock down cells results in a more than 4-fold increase in the number of multinucleated cells. Our results suggest that myosin VI has novel functions in mitosis and plays an essential role in targeted membrane transport during cytokinesis.
Introduction:
When a single cell divides into two daughter cells the chromosomes are segregated in mitosis and then the cytoplasm and the plasma membrane are divided during cytokinesis to complete the cell cycle (Scholey et al., 2003) . The process of cytokinesis is driven by the formation and constriction of an actomyosin II contractile ring and by targeted membrane addition (Glotzer, 2005) . Membrane delivery is first required during cleavage furrow ingression to increase the surface area of the two daughter cells and later during the absission process to seal the two newly formed cells (Albertson et al., 2005 ) (Strickland and Burgess, 2004) . Although membrane vesicles delivered into the cleavage furrow were believed to be derived from the secretory pathway (Skop et al., 2001 ), endocytosis and membrane recycling have also now been shown to be required for cytokinesis (Gerald et al., 2001 ) (Schweitzer and D'Souza-Schorey, 2002 ) . Endocytosis resumes during late cytokinesis and endocytic vesicles or vesicles from the recycling compartment are transported into the midbody region of the cleavage furrow (Schweitzer et al., 2005) .
Since myosin VI is an actin-based motor protein involved in endocytic and exocytic membrane trafficking pathways in interphase cells (Buss et al., 2004) , we decided to test whether it was involved in cytokinesis in dividing cells. An increasing number of proteins associated with the actin and microtubule cytoskeleton and with membrane trafficking pathways have been shown to play a role in cytokinesis. In a recent proteomic study by Skop et al., (2004) 160 candidate midbody proteins were identified including myosin VI and its binding partner GAIP-interacting protein COOH terminus (GIPC).
Furthermore, functional studies in C. elegans using RNA interference showed that both proteins display defects in germline cytokinesis (STE/GON) (Skop et al., 2004) .
Myosin VI is a retrograde motor because, unlike all the other classes of myosins, it moves towards the minus end of actin filaments (Wells et al., 1999) and is therefore expected to have unique and distinct intracellular functions. The targeting and functions of myosin VI at different intracellular locations involves a variety of different binding partners such as disabled-2 (Dab2) (Morris et al., 2002) , GIPC (Bunn et al., 1999) and optineurin (Sahlender et al., 2005) and also requires binding to PIP2 in the plasma membrane (Spudich et al., 2006) . GIPC is a PDZ domain containing protein that interacts with myosin VI and with the cytoplasmic domains of several transmembrane receptors at the plasma membrane, where it may regulate endocytic receptor trafficking or intracellular signalling (De Vries et al., 1998) .
In this study we examined the role of myosin VI and its binding partner GIPC during cell division in mammalian cells. In prophase in early mitosis myosin VI is present in the pericentriolar region. At the onset of cytokinesis myosin VI is recruited to the contractile ring in the cleavage furrow colocalising with actin and myosin II and after ingression it is found in the region of the midbody, where it colocalises with GIPC. In time-lapse video microscopy myosin VI can be seen associated with vesicles transported into and out of the midbody region, suggesting that it is involved in membrane trafficking during cytokinesis. Only the full-length "active' myosin VI but not the "non-functional" tail domain is targeted into the cleavage furrow and midbody. Over expression of this dominant negative tail inhibits delivery of vesicles containing the transferrin receptor (TfR) into the midbody region and results in multinucleated cells. In addition depletion of myosin VI or its binding partner GIPC, using siRNA leads to defects in cytokinesis.
Furthermore, loss of myosin VI in KD cells causes a dramatic delay in progression through metaphase and in chromosome alignment.
These results highlight for the first time a role for myosin VI in the progression of mitotic cells through metaphase and demonstrate that myosin VI plays an important role in membrane trafficking events during cytokinesis.
Material and Methods

Antibodies
The following antibodies were used: an rabbit antibody to myosin VI (Buss et al., 1998) ; a rabbit antibody to calf thymus non-muscle myosin II (Drenckhahn et al., 1983) ; a monoclonal antibody to GFP (Qbiogen, Cambridge, UK); a polyclonal antibody to GFP (Molecular Probes, Leiden, NL); a monoclonal antibody to alpha tubulin (Sigma, Gillingham, UK); a monoclonal antibody to transferrin receptor (Zymed, Cambridge BioScience, UK); a rabbit polyclonal antibody to GIPC and a rabbit antibody to actin (Sigma, Gillingham, UK). Rhodamine coupled phalloidin (Sigma, Gillingham, UK) was used to visualise F-actin filaments in immunofluorescence.
Cell culture and transfection
HeLa cells were cultured and transfected as described before (Sahlender et al., 2005) .
After 16-18 h the cells were either used for live cell imaging or fixed for immunofluorescence. MDCK II (Madin Darby Canine Kidney) cells were cultured in D-MEM containing 10% (v/v) fetal calf serum, 2 mM L-glutamine, 100U/ml penicillin and 0.1mg/ml streptomycin. Myosin VI or the tail domain tagged with GFP at the N-terminus was cloned into the ΔpMEP4 vector (Warner et al., 2003) . Protein expression was induced for 24 h with 100μM ZnCl 2 . For selection of stable MDCK cell lines, MDCK cells were tranfected as described above and selected with 200μg/ml Hygromycin (Roche Diagnostics, Lewes, UK). Single clones were isolated and the population of highly expressing cells enriched by FACS sorting. Immunoblotting of stable cell lines showed that the concentration of expressed protein was at least equal to that of endogenous myosin VI (Au et al., 2007) .
Knockdown of myosin VI and GIPC by siRNA
SiRNA knock down experiments were performed as described previously (Sahlender et al., 2005) . "On target Plus" smart pools designed and supplied by Dharmacon (Cramlington, UK) were used for knock down of myosin VI and GIPC. To perform siRNA-rescue experiments three silent point mutations were made in the target sequence of one of the myosin VI smart pool oligos using Quick Change (Stratagene, Netherlands). A stable HeLa cell line was generated expressing GFP-tagged mutated siRNA-resistant myosin VI using pIRESneo2 (Clontech-Takara, France).
Indirect immunofluorescence microscopy
HeLa and MDCK cells were processed for immunofluorescence microscopy as described previously (Buss et al., 2001) . To remove cytosolic proteins before fixation, MDCK cells expressing GFP-myosin VI or GFP-tail were pre-permeabilized with 0.05 % saponin in cytosol buffer (Morris and Cooper, 2001 ). Cells were analysed and photographed using a Zeiss LSM 510 confocal microscope.
Fluorescence live cell microscopy
For time-lapse fluorescence microscopy MDCK cells expressing GFP-myosin VI were grown on 25 mm diameter glass coverslips. Images were acquired with a 63x objective and a spinning disk confocal head (Perkin Elmer, Beaconsfield, UK) coupled to Zeiss Axiovert 135TV fluorescence microscope. Images were captured with Hamamatsu ORCA-ER camera controlled by the UltraView imaging software (Perkin Elmer, Beaconsfield, UK). Fluorescence images were acquired every 10 s and processed using Image J software (http://rsb.info.nih.gov/ij/).
DIC live cell microscopy
For time lapse DIC microscopy control or KD HeLa cells were grown on 25 mm round coverslips that were mounted in an Attofluor cell chamber (Molecular Probes, Leiden, NL), which was filled with CO 2 -independent medium (Invitrogen, Paisley, UK) and placed in a heated stage at 37°C on a Zeiss Axiovert 200M microscope (Zeiss, Welwyn Garden City, UK). DIC images were acquired every 2 min with Openlab and analysed using Velocity software (Improvision, Coventry, UK).
Whole mount immunocytochemistry
Whole mount immunocytochemistry was performed as previously described (Stoorvogel et al., 1996) (van Dam and Stoorvogel, 2002) . HeLa cells were cultured overnight on formvar carbon coated gold grids mounted on glass coverslips. The cells were washed with ice cold PBS and cytosolic proteins extracted with PBS containing 1 mM EGTA, 0.5 mM MgCl 2 , 0.5 mg/ml saponin (Sigma, Poole, UK) before fixation with 1% paraformaldehyde at 4° for 1h. The cells were then incubated in blocking buffer (PBS, 0.5 mg/ml saponin, 20 mM glycine, 0.1 % cold water fish gelatin and 0.02 % NaN 3 ) before immunolabelling (Slot et al., 1991) with a polyclonal antibody to myosin VI tail (Buss et al., 1998) followed by protein A 10 nm gold.
Results
Localisation of myosin VI in dividing cells
We have shown that in interphase cells myosin VI is present in membrane ruffles at the plasma membrane, in the perinuclear region at/around the Golgi complex and in vesicles throughout the cell (Buss et al., 1998) (Buss et al., 2001 ) (Warner et al., 2003) . To investigate the localisation of myosin VI in dividing cells, we immuno-stained MDCK cells with different myosin VI tail antibodies and also examined stable MDCK cell lines expressing GFP-tagged myosin VI. Both approaches showed that at the onset of mitosis, during prophase and prometaphase, myosin VI is present in a vesicular, punctate staining pattern concentrated at the centrosome/spindle poles ( Fig. 1 a-c and g-i) . In late anaphase/early telophase myosin VI is recruited to the plasma membrane surrounding the ingressing cleavage furrow (Fig. 3 A and Fig. 4 a-c) and in later stages of cytokinesis it is concentrated on either side of the midbody region ( Fig. 1 d-f and j-l, Fig. 2, Fig. 3 A, B and C and Fig. 4 d-f ). This very distinct recruitment of myosin VI to the spindle poles and the cleavage furrow and subsequently to the cytoplasmic bridge on either side of the midbody during cytokinesis was observed in immunofluorescence microscopy initially with different affinity purified antibodies to myosin VI and then confirmed by expression of full length GFP-tagged myosin VI (Fig.1 g-l) . To obtain higher resolution images of myosin VI in the midbody region, we performed whole mount immunoelectron microscopy on HeLa cells grown on formvar carbon coated gold grids. In this method cytosolic proteins were removed before fixation and labelling with our rabbit polyclonal antibody to myosin VI tail. Consistent with the immunofluorescence data myosin VI is present along cytoskeletal structures on either side of the very electron-dense area of the midbody (Fig. 2 a) . Enlarged images highlight the association of myosin VI with small intracellular vesicular structures of approximately 50 nm in size (arrows in Fig. 2 b, c and d) and with fibrous cytoskeletal elements.
Four different splice variants of myosin VI either containing no insert, a small insert, a large insert or both inserts in the tail domain are expressed in mammalian cells in a tissue specific manner. In polarised MDCK cells all myosin VI isoforms except the one with the small insert are expressed. Whereas the presence of the large insert appears to increase the affinity of myosin VI for clathrin coated endocytic structures (Spudich et al., 2006) , the no insert isoform is important for protein sorting in the exocytic pathway leading to delivery to the basolateral domain in polarised epithelial cells (Au, 2007) . All three myosin VI isoforms that are expressed in MDCK cells, show the same localisation in mitotic cells, indicating that in contrast to the localisation of myosin VI isoforms in interphase cells, the inserts do not appear to play a role in differential targeting of myosin VI in mitotic cells (data not shown).
Myosin VI is present on vesicular structures trafficking into and out of the midbody region
During cytokinesis, constriction of the cleavage furrow requires an increase in plasma membrane surface area. This is achieved by inserting new membrane into the cleavage furrow, which is either derived from the secretory or endocytic pathways. In interphase cells myosin VI is associated with endocytic and exocytic vesicles as well as the Golgi complex (Warner et al., 2003) (Buss et al., 1998) . Therefore, in order to explore whether myosin VI plays a role in directing membrane vesicles into the cleavage furrow, we used time-lapse video microscopy on MDCK cells stably expressing GFP-myosin VI. The dynamic behaviour of myosin VI tagged with GFP during cytokinessis can be seen in still images in figure 3 . At the onset of cytokinesis myosin VI is recruited and concentrated in the region of the plasma membrane, where the actin/myosin II contractile ring is being assembled (figure 4) and the plasma membrane is starting to invaginate (figure 3 A, supplementary movie 1). During cleavage furrow ingression myosin VI becomes very concentrated in the narrow cytoplasmic bridge on either side of the midbody. At the end of cytokinesis myosin VI is gradually lost from the midbody region. In addition to the concentration of myosin VI in the cleavage furrow we also observed the recruitment of myosin VI to the plasma membrane outside the cleavage furrow and to punctate structures in the polar regions surrounding the spindle poles, which are most likely membrane vesicles (sup. movie 1). Myosin VI is present on punctate structures that are moving from both daughter cells into the cytoplasmic bridge as shown on selected frames in figure 3 B (sup. movie 2). In the left daughter cell a small myosin VI containing structure (highlighted by a arrow) is budding from a larger fluorescent structure before moving rapidly in 30 seconds into the midbody region. In this movie equal numbers of myosin VI-positive spots are moving into and out of the cleavage furrow. This movement of myosin VI containing punctate structures movement can not only be observed in the cleavage furrow, but a large number of myosin VI-positive dots are moving in and out of the polar region around the spindle poles and around the perinuclear region adjacent to the cleavage furrow ( fig. 3 C and sup. movie 3). In some cells myosin VI positive dots were observed moving on a fixed possible cytoskeletal track between the polar region and the cleavage furrow (sup. movie 4). Unfortunately, we were unable to investigate the nature of this very intriguing but delicate track, since we were unable to visualise this track in cells after fixation. During late cytokinesis when the intercellular bridge is lengthening myosin VI positive spots now move predominantly away from the midbody into the cell (sup. movie 5). At this time myosin VI may transport endocytic vesicles out of the cytoplasmic bridge and into the cell, since it was recently reported (Schweitzer et al., 2005) that endocytosis resumes in late cytokinesis in the midbody region.
Our observations on the dynamic behaviour of GFP-myosin VI in live cells suggests that myosin VI is involved in trafficking of vesicles into and out of the cleavage furrow during cytokinesis.
The myosin VI tail is not targeted into the cleavage furrow
Previously we showed that the intracellular localisation of myosin VI to vesicular structures in the endocytic and secretory pathways requires the C-terminal cargo-binding domain (Buss et al., 2001 ) (Warner et al., 2003) (Sahlender et al., 2005) . The targeting of myosin VI to membrane compartments is mediated by a number of different binding partners or by interaction with phospholipids (Spudich et al., 2006) . Whereas the tail domain is sufficient for targeting to clathrin coated structures at the plasma membrane, the recruitment of myosin VI into membrane ruffles at the leading edge of a moving cells also requires its motor domain (Buss et al., 1998) .
To establish whether the tail domain of myosin VI is sufficient for targeting into the cleavage furrow during cytokinesis, we compared the localisation of full-length GFPmyosin VI and the GFP-tail in a double labelling experiment with a polyclonal antibody to non-muscle myosin II to visualise the contractile ring, since we observed that both myosin II and actin are concentrated in the intercellular bridge of MDCK cells ( figure 1 and 4 and supplementary figure 3). Whereas the full length myosin VI shows very good colocalisation with myosin II in the contractile ring in the ingressing cleavage furrow (figure 4, a-c) and afterwards in the midbody region (figure 4, d-f), the GFP-tail showed no cytokinesis specific labelling pattern (figure 4, g-i and j-l). The tail domain was targeted to punctate, vesicular structures in dividing cells (figure 4 g and j), which were often concentrated in the polar regions surrounding the spindle poles (see figure 7 g ), but no colocalisation with myosin II in the cleavage furrow or the midbody region was observed (figure 4 g and h, j and k).
Inhibition of myosin VI activity delays mitotic progression and leads to cytokinesis defects
To probe the function of myosin VI during cell division we used two different approaches. First we inhibited myosin VI activity by overexpressing a dominant negative tail mutant of myosin VI in MDCK cells. We used MDCK cell lines that have been generated and characterised recently (Au, 2007) and in which protein expression can be induced by addition of ZnCl 2 . A dominant negative approach has been used successfully to inhibit myosin VI dependent functions in the endocytic and exocytic pathway (Buss et al., 2001 ) (Swiatecka-Urban et al., 2004) (Au, 2007) . To quantify defects in cytokinesis caused by over expression of the dominant negative tail mutant, we induced expression of the myosin VI wild type tail, myosin VI tail mutant (with a mutation RRL->AAA that affects GIPC binding) or full-length myosin VI for 24 -36 h and compared the number of multinucleated cells with wild type MDCK cells (control) (Fig. 5 A) . Only over expression of the dominant negative wild type tail gave a significant and consistent 8 fold increase in the number of multinucleated cells (from less then 1% to 8%), therefore demonstrating an increase in cytokinesis failure. The mutant myosin VI tail, however, with the amino acid change (RRL to AAA; aa 1107-1109) that abolishes optineurin and GIPC binding, is no longer able to block GIPC-mediated myosin VI function and therefore does not cause any increase in multinucleation (Fig. 5 A) . As a second approach to manipulate myosin VI function we used siRNA oligonucleotides to silence myosin VI expression. For these experiments we changed form MDCK to HeLa cells, which give much higher siRNA transfection rates, and siRNA smartpools are easily obtainable for all human genes. These cells were transfected with a smartpool containing four different siRNAs specific for myosin VI. After transfection myosin VI expression levels were Finally we also observed a significant increase in the number of cells in metaphase, when myosin VI was depleted by siRNA suggesting that progression through metaphase was delayed (supplementary figure 1). To further investigate this result we followed mock treated and knock down (KD) cells through mitosis using DIC microscopy. In HeLa control cells more then 95 % of cells (N= 23) proceeded into anaphase within 30 min after the cells had started to assemble chromosomes at the metaphase plate. In myosin VI KD cells, however, nearly all the cells took more than 30 min to go through metaphase and to enter anaphase and 70% of the cells (N=24) took more than 60 min to reach anaphase. These results suggest that myosin VI may also play a role in chromosome alignment during metaphase.
Myosin VI mediates the insertion of TfR containing endosomes into the midbody region
The insertion of membranes from the endocytic and secretory pathway into the cleavage furrow is crucial for successful completion of cytokinesis. Since myosin VI has been localised in clathrin coated and uncoated endocytic structures (Buss et al., 2001 ) (Aschenbrenner et al., 2003) we next examined whether myosin VI is involved in delivery of endocytic material into the cleavage furrow. In MDCK cells expressing GFPmyosin VI or GFP-myosin VI tail we labelled the endocytic compartment with an antibody to the transferrin receptor. This receptor is taken up into mammalian cells via clathrin-mediated endocytosis and after passing through a recycling endosome is trafficked back to the cell surface or into the midbody region. GFP-myosin VI and GFPmyosin VI tail both showed very good colocalisation with the transferrin receptor positive compartment, possibly the recycling endosome, in the region around the spindle pole (Fig. 7 a-c and g-i, arrowheads) . However, in the midbody region we only observed colocalisation between full-length myosin VI and the TfR (Fig. 7 a-c, arrow) , since in cells expressing GFP-myosin VI tail there was no TfR and very little myosin VI tail was detected in the midbody region (Fig. 7 g-i) . Our confocal images also demonstrated limited but significant colocalisation of GFP-myosin VI with TfR positive endosomes in close vicinity to the midbody region (Fig. 7 d-f, arrowheads) , which might represent the myosin VI-positive vesicle population moving into and out of the cytoplasmic bridge that we observed in our live cell studies. These results indicate that the myosin VI tail domain is able to inhibit as a dominant negative mutant the transport of TfR positive endocytic vesicles into the midbody region.
Finally we investigated whether myosin VI is also associated with the secretory pathway during cytokinesis, since in interphase cells myosin VI can be found at the Golgi complex and in exocytic membrane trafficking pathways. During cytokinesis, however, very little myosin VI was associated with the Golgi fragments in the polar region stained with antibodies to the Golgi matrix protein GM130 (supplementary figure 2) . Furthermore, no colocalisation of myosin VI with GM130 or proteins involved in post Golgi membrane trafficking in the midbody region was observed (supplementary figure 2).
GIPC colocalises with myosin VI in the midbody region and loss of GIPC results in increased number of multinucleated cells
Targeting of myosin VI to distinct intracellular compartments requires binding to a number of different binding partners. The study by Skop et al indicated that not only myosin VI but also GIPC, a myosin VI binding partner, is present in isolated midbodies (Skop et al., 2004) . GIPC, a small PDZ domain containing protein, colocalises with myosin VI on endocytic vesicles (Aschenbrenner et al., 2003) and has been shown to bind to a number of transmembrane receptors at the cell surface and the Golgi complex in interphase cells (Katoh, 2002) . Using polyclonal antibodies to GIPC we observed a striking localisation of GIPC on either side of the midbody region colocalising with GFP-tagged myosin VI in MDCK cells (Fig. 8, d-f ). There was a perfect overlap between myosin VI and GIPC in the midbody region and on vesicular structures on either side of the cleavage furrow (Fig. 8, g-i) . In addition both proteins were recruited to the walls of the cleavage furrow during late anaphase/telophase (Fig. 8 a-c) . These results strongly suggest that a complex between myosin VI and GIPC may be essential for myosin VI to function during cytokinesis. This finding is supported by the observation that the myosin VI tail, where the GIPC binding site is mutated (RRL to AAA) (Spudich et al., 2007) has no dominant negative inhibitory effect on the function of myosin VI during cytokinesis (Fig. 5 A) .
To investigate the role of GIPC in dividing cells, we used a GIPC smartpool to ablate GIPC expression in HeLa cells. Immunoblotting analysis indicated that transfection with GIPC siRNA oligos very efficiently depleted the expression of GIPC (Fig 8 B) . In GIPC KD cells we observed a more than 4 fold increase in the number of multinucleated cells (13%) compared to mock transfected HeLa cells (3%) (Fig. 8 C) . These results indicate that the loss of GIPC and myosin VI both lead to defects in cytokinesis and suggest that both proteins might be involved in the final abscission step in cell division.
Discussion
In this study we have shown that in dividing cells myosin VI has novel roles during both mitosis and cytokinesis. In cells undergoing cell division we show that myosin VI at the beginning of prophase is concentrated around the centrosome. Whereas during cytokinesis myosin VI is present on the walls of the ingressing cleavage furrow and on vesicles moving into and out of the midbody region, where the myosin VI binding partner GIPC can also be found. The loss of myosin VI function induced by siRNA oligonucleotides or by dominant negative over expression of the tail leads to defects in cytokinesis. In addition, we also observed a delay in chromosome congression at the metaphase plate highlighting an unexpected function of myosin VI during spindle assembly and chromosome gathering. Although these latter events were generally believed to be microtubule-driven processes, it was recently demonstrated that in oocytes a contractile network of actin filaments captures chromosomes and brings them close to the spindle for microtubule attachment (Lenart et al., 2005) . Overall the role of actin filaments in chromosome capture and congression may not be restricted solely to large oocytes, but may also operate in other smaller somatic cells undergoing mitosis. In these cells an increasing number of actin-regulating proteins such as the Rho GTPase cdc42 and its effector mDia have been shown to be important for cell cycle progression (Yasuda et al., 2004) . These proteins induce actin filament nucleation and polymerisation and regulate microtubule attachment to kinetochores and chromosome alignment at the metaphase plate. Therefore it may not come as a surprise that myosin VI, a unique actin based motor protein, is recruited to centrosomes/spindle poles during prophase.
However, the loss of myosin VI in knock down cells does not lead to a complete mitotic arrest. In addition in fibroblasts isolated from the myosin VI knock out mouse (Snell's waltzer mouse) no major defects in chromosome alignment or spindle morphology were observed. These results suggest that redundant pathways exist for spindle assembly and chromosome congression in mammalian cells. The prometaphase delay in myosin VI knock down cells is very similar to the one described recently for Clip 170 KD cells (Dujardin et al., 1998) (Tanenbaum et al., 2006) . Clip 170 was identified as a myosin VI binding partner in Drosophila (Lantz and Miller, 1998) , however in mammalian cells we have not been able to confirm by yeast-2-hybrid or mammalian 2-hybrid assays or by coimmunoprecipitation any interaction between myosin VI and Clip 170. So far we were only able to demonstrate direct binding of Clip 170 to myosin VI in a GST pull down assay using recombinant GST tagged myosin VI tail and in vitro expressed Clip 170 (data not shown).
The midbody has a complex multi-component structure that forms between dividing cells during cytokinesis. A recent proteomics study identified myosin VI and GIPC as mammalian midbody proteins and highlighted a role for these two proteins in germline cytokinesis in C. elegans (Skop et al., 2004) . We have confirmed the localisation of GIPC in the midbody region in mammalian cells and furthermore shown that in siRNA knock down experiments the loss of GIPC leads to a dramatic failure in cytokinesis resulting in binucleated and multinucleated cells. Detailed immunolocalisation studies show that GIPC is concentrated on either side of the midbody and in double labelling experiments GIPC shows a dramatic overlap with myosin VI in the cleavage furrow on either side of the midbody.
Membrane trafficking is an essential part of cytokinesis for delivering and regulating the addition of new membrane along the ingressing cleavage furrow (Albertson et al., 2005 ) (Strickland and Burgess, 2004) . The importance of membrane fusion events during cytokinesis is highlighted by the requirement of SNARE proteins (Low et al., 2003) . The new membrane delivered into the cleavage furrow may be derived from the secretory, endocytic or recycling pathways. In some cell systems brefeldin A inhibits cytokinesis indicating that Golgi derived membrane trafficking is involved (Skop et al., 2001 ).
Furthermore proteomic analysis of mammalian midbodies identified a number of Golgiderived proteins (Skop et al., 2004) . Since myosin VI plays a role in exocytic membrane trafficking pathways, it could be involved together with its binding partner optineurin in transporting Golgi-derived vesicles into the midbody region (Warner et al., 2003) (Sahlender et al., 2005) . However, so far we have not observed any colocalisation of myosin VI with any Golgi fragments in dividing cells or any targeting of optineurin into the cleavage furrow during cytokinesis. Furthermore, depletion of optineurin by siRNA does not result in a cytokinesis defect and multinucleation. These results indicate that myosin VI is apparently not involved in the transport of secretory vesicles into the midbody area.
Endocytosis and membrane recycling are however crucial for cytokinesis, since proteins essential for these processes such as clathrin, caveolin, dynamin, Arf6 and Rab11 are required (Gerald et al., 2001 ) (Kogo and Fujimoto, 2000) (Schweitzer and D'SouzaSchorey, 2002) . Recently, it has been shown that in early telophase, endocytosis resumes at the polar regions of the dividing cell (Schweitzer et al., 2005) . In this study it was demonstrated that endocytosed transferrin accumulates first in vesicles around the spindle poles and then these vesicles are transported to the cleavage furrow in late cytokinesis.
Given the localisation of myosin VI in vesicles surrounding the spindle poles and in vesicles moving into the midbody region, myosin VI is most likely to be a driving force for the transport of vesicles from the pericentriolar vesicular compartment into the cleavage furrow, since inhibition of myosin VI function dramatically reduces the amount of TfR containing vesicles transported into the midbody region. The tail domain of myosin VI targets to vesicles in the pericentriolar region but not to the cleavage furrow, indicating that the dominant negative tail inhibits the formation and/or transport of vesicles away from the pericentriolar recycling/sorting endosome. Although the exact nature of this pericentriolar compartment needs to be established, our previous work has shown that ablating myosin VI function in polarised MDCK cells perturbs the correct sorting of cargo to the basolateral domain (Au et al. 2007) . This sorting step is believed to involve the transferrin positive recycling endosome, which may be a very similar compartment to that in the pericentriolar region in cells undergoing cytokinesis.
In the final stages of cytokinesis our live cell movies indicate that myosin VI containing vesicles not only move into the cleavage furrow, but predominately move away from the midbody back into the cell. Since work by Schweitzer et al. has shown that endocytosis resumes from the midbody region at the end of cytokinesis (Schweitzer et al., 2005) , it is likely that at this stage myosin VI may be transporting endocytic membranes back into the cell.
During cytokinesis actin filament assemble not only as a circumferential belt as part of the contractile ring, but also align themselves along the spindle axis in a complex threedimensional network (Fishkind and Wang, 1993) . Although the polarity of these actin filaments is not known there is an obvious need for a reverse directed motor such as myosin VI however, at present its precise function has not been identified.
The movement of myosin VI to the centrosome in early mitosis and into the cleavage furrow and the midbody region appears to involve interaction with specific binding partners such as GIPC. A minor mutation (RRL->AAA) prevents GIPC binding to the myosin VI tail (Spudich et al., 2007) and it abolishes the ability of the tail to cause cytokinesis defects. Targeting of myosin VI to the ingressing cleavage furrow might also involve its high affinity-binding site for PIP2 in the C-terminal tail domain (Spudich et al., 2007) , which we have recently identified. Several studies have recently shown that PtdIns(4,5)P 2 (PIP 2 ) accumulates at the cleavage furrow and that its presence is necessary for successful furrow ingression during cytokinesis (Field et al., 2005) (Janetopoulos and Devreotes, 2006) (Janetopoulos et al., 2005) (Emoto et al., 2005) .
The dual localisation of myosin VI in dividing cells at/around the centrosome in early mitosis and later in the midbody region during cytokinesis is very intriguing and future experiments will be required to determine whether myosin VI displays separate independent functions during prometaphase at the centrosome and during cytokinesis or whether it is part of the signalling networks that coordinate/regulate mitosis, cytokinesis and abscission. 
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